Table 4.
DCE-MR parameter | Malignant ovarian masses (n = 108) |
Sensitivity (%) | Specificity (%) | Accuracy (%) | |
---|---|---|---|---|---|
Borderline 26 (24) | Invasive malignant 82 (76) | ||||
Maximum relative enhancement percentage | |||||
<120 | 7 (6.4) | 23 (21.3) | 72 | 73 | 72.2 |
>120 | 19 (17.6) | 59 (54.6) | |||
Time of initial peak of maximal uptake (s) | |||||
>200 | 15 (13.9) | 33 (30.5) | 59.7 | 57.7 | 59.2 |
<120 | 11 (10.2) | 49 (45.4) | |||
Slope enhancement ratio curves | |||||
Type I–II | 16 (14.8) | 31 (28.7) | 62.2 | 61.6 | 62 |
Type III | 10 (9.3) | 51 (47.2) |
Data are reported as number (percent).